InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IFRX InflaRx N.V.

交易中 06-17 11:46:54 EDT

1.50

-0.06

-3.85%

最高1.54	最低1.48	成交量3,797
今开1.54	昨收1.56	日振幅3.85%
总市值8,832万	流通市值7,323万	总股本5,888万
成交额5,756	换手率0.01%	流通股本4,882万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IFRX","market":"US","secType":"STK","nameCN":"InflaRx N.V.","latestPrice":1.5,"timestamp":1718638883727,"preClose":1.56,"halted":0,"volume":3797,"delay":0,"floatShares":48818407,"shares":58883272,"eps":-0.760986,"marketStatus":"交易中","marketStatusCode":2,"change":-0.06,"latestTime":"06-17 11:46:54 EDT","open":1.54,"high":1.54,"low":1.48,"amount":5756.1210035,"amplitude":0.038462,"askPrice":1.54,"askSize":350,"bidPrice":1.5,"bidSize":3019,"shortable":3,"etf":0,"ttmEps":-0.760986,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1718654400000},"adr":0,"listingDate":1510117200000,"adjPreClose":1.56,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":1.56,"preClose":1.56,"latestTime":"16:00 EDT","volume":5,"amount":7.800000000000001,"timestamp":1718395201320},"volumeRatio":0.12939,"impliedVol":1.388,"impliedVolPercentile":0.8367},"requestUrl":"/m/hq/s/IFRX/wiki","defaultTab":"wiki","newsList":[{"id":"2444193127","title":"Inflarx N.V.盘中异动 早盘大幅下挫5.13%报1.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444193127","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444193127?lang=zh_cn&edition=full","pubTime":"2024-06-17 22:26","pubTimestamp":1718634418,"startTime":"0","endTime":"0","summary":"北京时间2024年06月17日22时26分，Inflarx N.V.股票出现异动，股价大幅跳水5.13%。截至发稿，该股报1.48美元/股，成交量1360股，换手率0.00%，振幅0.00%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.26%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722265896814a65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061722265896814a65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2443016526","title":"Inflarx N.V.盘中异动 下午盘急速上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443016526","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443016526?lang=zh_cn&edition=full","pubTime":"2024-06-15 02:47","pubTimestamp":1718390822,"startTime":"0","endTime":"0","summary":"北京时间2024年06月15日02时47分，Inflarx N.V.股票出现波动，股价大幅上涨5.26%。截至发稿，该股报1.60美元/股，成交量7.29万股，换手率0.12%，振幅7.89%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.14%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024702968145d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240615024702968145d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2443849116","title":"Inflarx N.V.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2443849116","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443849116?lang=zh_cn&edition=full","pubTime":"2024-06-13 22:20","pubTimestamp":1718288446,"startTime":"0","endTime":"0","summary":"北京时间2024年06月13日22时20分，Inflarx N.V.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报1.51美元/股，成交量5.6912万股，换手率0.10%，振幅2.52%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.36%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613222047af8d6f3d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240613222047af8d6f3d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LGVN","IFRX","BK4139"],"gpt_icon":0},{"id":"2442631465","title":"Inflarx N.V.盘中异动 快速下挫5.70%报1.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442631465","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442631465?lang=zh_cn&edition=full","pubTime":"2024-06-12 00:54","pubTimestamp":1718124886,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日00时54分，Inflarx N.V.股票出现波动，股价大幅跳水5.70%。截至发稿，该股报1.49美元/股，成交量8260股，换手率0.01%，振幅2.85%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.20%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005447941edc9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612005447941edc9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2441764092","title":"Inflarx N.V.盘中异动 股价大跌6.17%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441764092","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441764092?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:30","pubTimestamp":1717785053,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时30分，Inflarx N.V.股票出现异动，股价大幅下跌6.17%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.30%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。消息层面，截至02时30分，《H.C. Wainwright维持InflaRx买入评级，维持目标价8美元》资讯为影响Inflarx N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608023054941ed5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608023054941ed5b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2441374407","title":"Inflarx N.V.盘中异动 临近午盘急速拉升5.06%报1.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441374407","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441374407?lang=zh_cn&edition=full","pubTime":"2024-06-06 23:59","pubTimestamp":1717689580,"startTime":"0","endTime":"0","summary":"北京时间2024年06月06日23时59分，Inflarx N.V.股票出现异动，股价快速上涨5.06%。截至发稿，该股报1.66美元/股，成交量7.1379万股，换手率0.12%，振幅5.70%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.85%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。消息层面，截至23时59分，《H.C. Wainwright维持InflaRx买入评级，维持目标价8美元》资讯为影响Inflarx N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606235940941ed024&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240606235940941ed024&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2441743382","title":"Inflarx N.V.盘中异动 股价大跌8.23%报1.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441743382","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441743382?lang=zh_cn&edition=full","pubTime":"2024-06-05 21:53","pubTimestamp":1717595581,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日21时53分，Inflarx N.V.股票出现异动，股价快速跳水8.23%。截至发稿，该股报1.45美元/股，成交量1301股，换手率0.00%，振幅8.23%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.19%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521530295915bb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060521530295915bb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2440479496","title":"Inflarx N.V.盘中异动 股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440479496","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440479496?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:01","pubTimestamp":1717423272,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时01分，Inflarx N.V.股票出现波动，股价急速上涨5.59%。截至发稿，该股报1.51美元/股，成交量2.5538万股，换手率0.04%，振幅5.59%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.05%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603220113aef30f2d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603220113aef30f2d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2439967467","title":"Inflarx N.V.盘中异动 下午盘大幅下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2439967467","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2439967467?lang=zh_cn&edition=full","pubTime":"2024-05-31 03:24","pubTimestamp":1717097093,"startTime":"0","endTime":"0","summary":"北京时间2024年05月31日03时24分，Inflarx N.V.股票出现异动，股价快速下挫5.14%。截至发稿，该股报1.39美元/股，成交量20.9417万股，换手率0.36%，振幅6.85%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.52%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531032454af8b2e06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240531032454af8b2e06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2437295467","title":"Inflarx N.V.盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437295467","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437295467?lang=zh_cn&edition=full","pubTime":"2024-05-22 21:39","pubTimestamp":1716385197,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日21时39分，Inflarx N.V.股票出现异动，股价急速拉升5.26%。截至发稿，该股报1.60美元/股，成交量1.5269万股，换手率0.03%，振幅2.63%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.35%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213957941e9724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522213957941e9724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2436946317","title":"Inflarx N.V.2024财年第一财季实现净利润-10.48百万美元，同比增加11.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436946317","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436946317?lang=zh_cn&edition=full","pubTime":"2024-05-18 00:11","pubTimestamp":1715962262,"startTime":"0","endTime":"0","summary":"3月31日，Inflarx N.V.公布财报，公告显示公司2024财年第一财季净利润为-10.48百万美元，同比增加11.86%；其中营业收入为39112.81美元，每股基本收益为-0.18美元。从资产负债表来看，Inflarx N.V.总负债13.32百万美元，其中短期债务408336.12美元，资产负债比为0.09，流动比率为0.09。机构评级：截至2024年3月31日，当前有4家机构对Inflarx N.V.目标价做出预测，其中目标均价为8.09美元，其中最低目标价为5.05美元，最高目标价为12.13美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180011088b13104b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405180011088b13104b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX"],"gpt_icon":0},{"id":"2435376684","title":"Inflarx N.V.盘中异动 早盘快速上涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2435376684","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435376684?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:58","pubTimestamp":1715608726,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日21时58分，Inflarx N.V.股票出现波动，股价急速拉升5.08%。截至发稿，该股报1.24美元/股，成交量5568股，换手率0.01%，振幅3.39%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.19%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321584687e8787e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051321584687e8787e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2434013859","title":"Inflarx N.V.盘中异动 早盘快速上涨5.77%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434013859","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434013859?lang=zh_cn&edition=full","pubTime":"2024-05-09 21:34","pubTimestamp":1715261656,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日21时34分，Inflarx N.V.股票出现波动，股价快速上涨5.77%。截至发稿，该股报1.27美元/股，成交量5252股，换手率0.01%，振幅3.43%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.35%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092134168aed0f86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405092134168aed0f86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2433731899","title":"Inflarx N.V.盘中异动 急速下挫5.02%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433731899","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433731899?lang=zh_cn&edition=full","pubTime":"2024-05-08 03:30","pubTimestamp":1715110233,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日03时30分，Inflarx N.V.股票出现异动，股价大幅跳水5.02%。截至发稿，该股报1.23美元/股，成交量10.5298万股，换手率0.18%，振幅6.18%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.20%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080330347a5889df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405080330347a5889df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2433470010","title":"Inflarx N.V.盘中异动 股价大跌5.07%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433470010","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433470010?lang=zh_cn&edition=full","pubTime":"2024-05-06 22:49","pubTimestamp":1715006965,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日22时49分，Inflarx N.V.股票出现异动，股价急速跳水5.07%。截至发稿，该股报1.31美元/股，成交量4.1009万股，换手率0.07%，振幅6.52%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为0.15%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506224925861eb35e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506224925861eb35e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2432817959","title":"Inflarx N.V.盘中异动 大幅下挫6.38%报1.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432817959","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432817959?lang=zh_cn&edition=full","pubTime":"2024-05-03 00:07","pubTimestamp":1714666027,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日00时07分，Inflarx N.V.股票出现波动，股价急速下跌6.38%。截至发稿，该股报1.32美元/股，成交量7.3643万股，换手率0.13%，振幅6.62%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.73%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300070787e855ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050300070787e855ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2431862926","title":"Inflarx N.V.盘中异动 早盘股价大涨6.02%报1.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431862926","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431862926?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:27","pubTimestamp":1714400838,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时27分，Inflarx N.V.股票出现异动，股价急速拉升6.02%。截至发稿，该股报1.41美元/股，成交量2.9752万股，换手率0.05%，振幅5.26%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.78%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292227187a573074&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292227187a573074&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2430821727","title":"Inflarx N.V.盘中异动 急速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430821727","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430821727?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:09","pubTimestamp":1714154995,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日02时09分，Inflarx N.V.股票出现波动，股价大幅下挫5.04%。截至发稿，该股报1.32美元/股，成交量5.1872万股，换手率0.09%，振幅7.12%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为0.47%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404270209557a56548f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0},{"id":"2430284920","title":"Inflarx N.V.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430284920","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430284920?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:24","pubTimestamp":1714055094,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时24分，Inflarx N.V.股票出现异动，股价急速下挫5.15%。截至发稿，该股报1.29美元/股，成交量1.9577万股，换手率0.03%，振幅2.21%。Inflarx N.V.股票所在的生物技术行业中，整体跌幅为1.66%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522245487e83c14&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522245487e83c14&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IFRX"],"gpt_icon":0},{"id":"2429113166","title":"Inflarx N.V.盘中异动 早盘快速上涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429113166","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429113166?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:55","pubTimestamp":1713880508,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时55分，Inflarx N.V.股票出现波动，股价急速上涨5.11%。截至发稿，该股报1.44美元/股，成交量6581股，换手率0.01%，振幅1.09%。Inflarx N.V.股票所在的生物技术行业中，整体涨幅为1.22%。Inflarx N.V.公司简介：InflaRx NV是一家临床生物制药公司，致力于应用专有的抗 C5a 技术来发现和开发称为 C5a 的补体激活因子的特异性抑制剂。它还在开发 IFX-1 来治疗 AAV，这是一种威胁生命的自身免疫性疾病，与严重的炎症发作相关，会损害肾功能并导致致命的器官功能障碍。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232155097922b10f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232155097922b10f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IFRX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inflarx.com","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.1143},{"period":"3month","weight":-0.0127},{"period":"6month","weight":0.1908},{"period":"1year","weight":-0.6494},{"period":"ytd","weight":-0.0429}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0646},{"period":"6month","weight":0.1565},{"period":"1year","weight":0.2263},{"period":"ytd","weight":0.1419}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"InflaRx N.V.于2017年6月根据荷兰法律成立，根据公司重组的条款，该公司是一家InflaRx GmbH的控股的公司。该公司是一家临床阶段的生物制药公司，专注于应用其独有的反C5a技术来发现和开发一种名为C5a的补充激活因子的一级、有效和特异性抑制剂。C5a是一种强大的炎症介质，涉及多种自身免疫和其他炎症疾病的进展。","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.090583},{"month":2,"riseRate":0.571429,"avgChangeRate":0.006427},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.068353},{"month":4,"riseRate":0.571429,"avgChangeRate":0.389384},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.049969},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.215022},{"month":7,"riseRate":0.333333,"avgChangeRate":0.114861},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.053477},{"month":9,"riseRate":0.5,"avgChangeRate":-0.032601},{"month":10,"riseRate":0.333333,"avgChangeRate":0.016141},{"month":11,"riseRate":0.5,"avgChangeRate":0.042008},{"month":12,"riseRate":0.714286,"avgChangeRate":0.137243}],"exchange":"NASDAQ","name":"InflaRx N.V.","nameEN":"InflaRx N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.23.1","shortVersion":"4.23.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"InflaRx N.V.,IFRX,InflaRx N.V.股票,InflaRx N.V.股票老虎,InflaRx N.V.股票老虎国际,InflaRx N.V.行情,InflaRx N.V.股票行情,InflaRx N.V.股价,InflaRx N.V.股市,InflaRx N.V.股票价格,InflaRx N.V.股票交易,InflaRx N.V.股票购买,InflaRx N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"InflaRx N.V.(IFRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供InflaRx N.V.(IFRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}